Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01169272

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
  • LivaNova Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01169272
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01169272. Non-randomized; no masking; primary purpose diagnostic. Start 2010-10 (registry gives no type); primary completion 2011-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Evaluation Of The SonR Atrial Lead In Paradym RF Device
Condition
Heart Failure
Intervention (Device)
CRT-SonR 9770
Lead sponsor
LivaNova (class: industry)

Record details

Record id
cardio:ct-nct01169272
Content hash
60809376a64cdab4d9e74e1cc872b12cd28ccf847e02d750358e5247e325f0ce